Global Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Comprehensive Study by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins, Other ), Application (Food-producing Animals, Companion Animals), Mode of Delivery (Premixes, Oral Powder, Injection) Players and Region - Global Market Outlook to 2032

Animal Antibiotics and Antimicrobials Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Animal Antibiotics and Antimicrobials
Increasing demand for pet insurance, rising animal health spending and Growing demand for animal-derived food products will help to fuel Animal Antibiotics and Antimicrobials in the forecasted period. Animal antibiotics and antimicrobials can be used in those animals which contribute to the development of antimicrobial resistance in bacteria that may be transmitted to persons, there for it decreases the efficiency of antimicrobial drugs for handling the human disease. Growing initiatives regarding animal health and welfare are anticipated to support the whole global market for animal antimicrobials and antibiotics.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


Analyst at AMA Research estimates that United States and Europeam Players will contribute the maximum growth to Global Animal Antibiotics and Antimicrobials market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Zoetis, Inc. (United States), Merck & Co., Inc. (United States), Bayer AG (Germany), Eli Lilly and Company (United States), Virbac (France), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), Sanofi (France) and Dechra Pharmaceuticals PLC (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Elanco Animal Health (United States) and Novartis International AG (Germany).

Segmentation Overview
AMA Research has segmented the market of Global Animal Antibiotics and Antimicrobials market by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins and Other ), Application (Food-producing Animals and Companion Animals) and Region.



On the basis of geography, the market of Animal Antibiotics and Antimicrobials has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Mode of Delivery, the sub-segment i.e. Premixes will boost the Animal Antibiotics and Antimicrobials market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Instances of Zoonotic Diseases will further Increase the Adoption and Continues Increase in Animal Health Expenditure

Market Growth Drivers:
Increasing Demand for Food Products Derived from Animals and Favorable Government Regulations in Preventing the Spread of Animal Diseases

Challenges:
Complex and Lengthy Approval Process for Antimicrobials and Antibiotics

Restraints:
Growing Threat of Substitutes such as New Antibiotics as well as it can be replaced by Good Husbandry and Hygiene Practices and Due to Increased Consumption, Growing Resistance Concerns to Antimicrobials and Antibiotics

Opportunities:
Upsurging Demand from the Untapped Emerging Economies and Robustly Growing Population for Companion Animals may further Increase the Demand




Key Target Audience
Animal Antibiotics and Antimicrobials Manufacturers, Animal Antibiotics and Antimicrobials Distributors and Traders, Upstream and Downstream Buyers, Government Agencies, Healthcare Industry Associations, Venture Capitalist, Animal Based Industry Associations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Etracyclines
  • Penicillins
  • Macrolides
  • Aminoglycosides
  • Sulfonamides
  • Fluoroquinolones
  • Lincosamides
  • Cephalosporins
  • Other 
By Application
  • Food-producing Animals
  • Companion Animals
By Mode of Delivery
  • Premixes
  • Oral Powder
  • Injection

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Food Products Derived from Animals
      • 3.2.2. Favorable Government Regulations in Preventing the Spread of Animal Diseases
    • 3.3. Market Challenges
      • 3.3.1. Complex and Lengthy Approval Process for Antimicrobials and Antibiotics
    • 3.4. Market Trends
      • 3.4.1. Rising Instances of Zoonotic Diseases will further Increase the Adoption
      • 3.4.2. Continues Increase in Animal Health Expenditure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Antibiotics and Antimicrobials, by Type, Application, Mode of Delivery and Region (value, volume and price ) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Animal Antibiotics and Antimicrobials (Value)
      • 5.2.1. Global Animal Antibiotics and Antimicrobials by: Type (Value)
        • 5.2.1.1. Etracyclines
        • 5.2.1.2. Penicillins
        • 5.2.1.3. Macrolides
        • 5.2.1.4. Aminoglycosides
        • 5.2.1.5. Sulfonamides
        • 5.2.1.6. Fluoroquinolones
        • 5.2.1.7. Lincosamides
        • 5.2.1.8. Cephalosporins
        • 5.2.1.9. Other 
      • 5.2.2. Global Animal Antibiotics and Antimicrobials by: Application (Value)
        • 5.2.2.1. Food-producing Animals
        • 5.2.2.2. Companion Animals
      • 5.2.3. Global Animal Antibiotics and Antimicrobials by: Mode of Delivery (Value)
        • 5.2.3.1. Premixes
        • 5.2.3.2. Oral Powder
        • 5.2.3.3. Injection
      • 5.2.4. Global Animal Antibiotics and Antimicrobials Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Animal Antibiotics and Antimicrobials (Volume)
      • 5.3.1. Global Animal Antibiotics and Antimicrobials by: Type (Volume)
        • 5.3.1.1. Etracyclines
        • 5.3.1.2. Penicillins
        • 5.3.1.3. Macrolides
        • 5.3.1.4. Aminoglycosides
        • 5.3.1.5. Sulfonamides
        • 5.3.1.6. Fluoroquinolones
        • 5.3.1.7. Lincosamides
        • 5.3.1.8. Cephalosporins
        • 5.3.1.9. Other 
      • 5.3.2. Global Animal Antibiotics and Antimicrobials by: Application (Volume)
        • 5.3.2.1. Food-producing Animals
        • 5.3.2.2. Companion Animals
      • 5.3.3. Global Animal Antibiotics and Antimicrobials by: Mode of Delivery (Volume)
        • 5.3.3.1. Premixes
        • 5.3.3.2. Oral Powder
        • 5.3.3.3. Injection
      • 5.3.4. Global Animal Antibiotics and Antimicrobials Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Animal Antibiotics and Antimicrobials (Price)
      • 5.4.1. Global Animal Antibiotics and Antimicrobials by: Type (Price)
  • 6. Animal Antibiotics and Antimicrobials: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co., Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Eli Lilly and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Virbac (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boehringer Ingelheim GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ceva Sante Animale (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vetoquinol S.A. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sanofi (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Dechra Pharmaceuticals PLC (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Animal Antibiotics and Antimicrobials Sale, by Type, Application, Mode of Delivery and Region (value, volume and price ) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Animal Antibiotics and Antimicrobials (Value)
      • 7.2.1. Global Animal Antibiotics and Antimicrobials by: Type (Value)
        • 7.2.1.1. Etracyclines
        • 7.2.1.2. Penicillins
        • 7.2.1.3. Macrolides
        • 7.2.1.4. Aminoglycosides
        • 7.2.1.5. Sulfonamides
        • 7.2.1.6. Fluoroquinolones
        • 7.2.1.7. Lincosamides
        • 7.2.1.8. Cephalosporins
        • 7.2.1.9. Other 
      • 7.2.2. Global Animal Antibiotics and Antimicrobials by: Application (Value)
        • 7.2.2.1. Food-producing Animals
        • 7.2.2.2. Companion Animals
      • 7.2.3. Global Animal Antibiotics and Antimicrobials by: Mode of Delivery (Value)
        • 7.2.3.1. Premixes
        • 7.2.3.2. Oral Powder
        • 7.2.3.3. Injection
      • 7.2.4. Global Animal Antibiotics and Antimicrobials Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Animal Antibiotics and Antimicrobials (Volume)
      • 7.3.1. Global Animal Antibiotics and Antimicrobials by: Type (Volume)
        • 7.3.1.1. Etracyclines
        • 7.3.1.2. Penicillins
        • 7.3.1.3. Macrolides
        • 7.3.1.4. Aminoglycosides
        • 7.3.1.5. Sulfonamides
        • 7.3.1.6. Fluoroquinolones
        • 7.3.1.7. Lincosamides
        • 7.3.1.8. Cephalosporins
        • 7.3.1.9. Other 
      • 7.3.2. Global Animal Antibiotics and Antimicrobials by: Application (Volume)
        • 7.3.2.1. Food-producing Animals
        • 7.3.2.2. Companion Animals
      • 7.3.3. Global Animal Antibiotics and Antimicrobials by: Mode of Delivery (Volume)
        • 7.3.3.1. Premixes
        • 7.3.3.2. Oral Powder
        • 7.3.3.3. Injection
      • 7.3.4. Global Animal Antibiotics and Antimicrobials Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Animal Antibiotics and Antimicrobials (Price)
      • 7.4.1. Global Animal Antibiotics and Antimicrobials by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Antibiotics and Antimicrobials: by Type(USD Million)
  • Table 2. Animal Antibiotics and Antimicrobials Etracyclines , by Region USD Million (2019-2024)
  • Table 3. Animal Antibiotics and Antimicrobials Penicillins , by Region USD Million (2019-2024)
  • Table 4. Animal Antibiotics and Antimicrobials Macrolides , by Region USD Million (2019-2024)
  • Table 5. Animal Antibiotics and Antimicrobials Aminoglycosides , by Region USD Million (2019-2024)
  • Table 6. Animal Antibiotics and Antimicrobials Sulfonamides , by Region USD Million (2019-2024)
  • Table 7. Animal Antibiotics and Antimicrobials Fluoroquinolones , by Region USD Million (2019-2024)
  • Table 8. Animal Antibiotics and Antimicrobials Lincosamides , by Region USD Million (2019-2024)
  • Table 9. Animal Antibiotics and Antimicrobials Cephalosporins , by Region USD Million (2019-2024)
  • Table 10. Animal Antibiotics and Antimicrobials Other  , by Region USD Million (2019-2024)
  • Table 11. Animal Antibiotics and Antimicrobials: by Application(USD Million)
  • Table 12. Animal Antibiotics and Antimicrobials Food-producing Animals , by Region USD Million (2019-2024)
  • Table 13. Animal Antibiotics and Antimicrobials Companion Animals , by Region USD Million (2019-2024)
  • Table 14. Animal Antibiotics and Antimicrobials: by Mode of Delivery(USD Million)
  • Table 15. Animal Antibiotics and Antimicrobials Premixes , by Region USD Million (2019-2024)
  • Table 16. Animal Antibiotics and Antimicrobials Oral Powder , by Region USD Million (2019-2024)
  • Table 17. Animal Antibiotics and Antimicrobials Injection , by Region USD Million (2019-2024)
  • Table 18. South America Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 19. South America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 20. South America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 21. South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 22. Brazil Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 23. Brazil Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 24. Brazil Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 25. Argentina Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 26. Argentina Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 27. Argentina Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 28. Rest of South America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 29. Rest of South America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 30. Rest of South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 31. Asia Pacific Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 32. Asia Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 33. Asia Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 34. Asia Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 35. China Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 36. China Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 37. China Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 38. Japan Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 39. Japan Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 40. Japan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 41. India Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 42. India Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 43. India Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 44. South Korea Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 45. South Korea Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 46. South Korea Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 47. Taiwan Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 48. Taiwan Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 49. Taiwan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 50. Australia Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 51. Australia Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 52. Australia Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 53. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 54. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 55. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 56. Europe Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 57. Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 58. Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 59. Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 60. Germany Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 61. Germany Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 62. Germany Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 63. France Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 64. France Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 65. France Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 66. Italy Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 67. Italy Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 68. Italy Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 69. United Kingdom Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 70. United Kingdom Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 71. United Kingdom Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 72. Netherlands Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 73. Netherlands Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 74. Netherlands Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 75. Rest of Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 76. Rest of Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 77. Rest of Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 78. MEA Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 79. MEA Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 80. MEA Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 81. MEA Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 82. Middle East Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 83. Middle East Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 84. Middle East Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 85. Africa Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 86. Africa Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 87. Africa Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 88. North America Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 89. North America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 90. North America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 91. North America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 92. United States Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 93. United States Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 94. United States Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 95. Canada Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 96. Canada Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 97. Canada Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 98. Mexico Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 99. Mexico Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 100. Mexico Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2019-2024)
  • Table 101. Animal Antibiotics and Antimicrobials Sales: by Type(K Tons)
  • Table 102. Animal Antibiotics and Antimicrobials Sales Etracyclines , by Region K Tons (2019-2024)
  • Table 103. Animal Antibiotics and Antimicrobials Sales Penicillins , by Region K Tons (2019-2024)
  • Table 104. Animal Antibiotics and Antimicrobials Sales Macrolides , by Region K Tons (2019-2024)
  • Table 105. Animal Antibiotics and Antimicrobials Sales Aminoglycosides , by Region K Tons (2019-2024)
  • Table 106. Animal Antibiotics and Antimicrobials Sales Sulfonamides , by Region K Tons (2019-2024)
  • Table 107. Animal Antibiotics and Antimicrobials Sales Fluoroquinolones , by Region K Tons (2019-2024)
  • Table 108. Animal Antibiotics and Antimicrobials Sales Lincosamides , by Region K Tons (2019-2024)
  • Table 109. Animal Antibiotics and Antimicrobials Sales Cephalosporins , by Region K Tons (2019-2024)
  • Table 110. Animal Antibiotics and Antimicrobials Sales Other  , by Region K Tons (2019-2024)
  • Table 111. Animal Antibiotics and Antimicrobials Sales: by Application(K Tons)
  • Table 112. Animal Antibiotics and Antimicrobials Sales Food-producing Animals , by Region K Tons (2019-2024)
  • Table 113. Animal Antibiotics and Antimicrobials Sales Companion Animals , by Region K Tons (2019-2024)
  • Table 114. Animal Antibiotics and Antimicrobials Sales: by Mode of Delivery(K Tons)
  • Table 115. Animal Antibiotics and Antimicrobials Sales Premixes , by Region K Tons (2019-2024)
  • Table 116. Animal Antibiotics and Antimicrobials Sales Oral Powder , by Region K Tons (2019-2024)
  • Table 117. Animal Antibiotics and Antimicrobials Sales Injection , by Region K Tons (2019-2024)
  • Table 118. South America Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2019-2024)
  • Table 119. South America Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 120. South America Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 121. South America Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 122. Brazil Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 123. Brazil Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 124. Brazil Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 125. Argentina Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 126. Argentina Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 127. Argentina Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 128. Rest of South America Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 129. Rest of South America Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 130. Rest of South America Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 131. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2019-2024)
  • Table 132. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 133. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 134. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 135. China Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 136. China Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 137. China Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 138. Japan Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 139. Japan Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 140. Japan Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 141. India Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 142. India Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 143. India Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 144. South Korea Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 145. South Korea Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 146. South Korea Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 147. Taiwan Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 148. Taiwan Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 149. Taiwan Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 150. Australia Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 151. Australia Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 152. Australia Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 153. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 154. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 155. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 156. Europe Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2019-2024)
  • Table 157. Europe Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 158. Europe Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 159. Europe Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 160. Germany Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 161. Germany Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 162. Germany Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 163. France Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 164. France Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 165. France Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 166. Italy Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 167. Italy Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 168. Italy Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 169. United Kingdom Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 170. United Kingdom Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 171. United Kingdom Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 172. Netherlands Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 173. Netherlands Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 174. Netherlands Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 175. Rest of Europe Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 176. Rest of Europe Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 177. Rest of Europe Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 178. MEA Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2019-2024)
  • Table 179. MEA Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 180. MEA Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 181. MEA Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 182. Middle East Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 183. Middle East Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 184. Middle East Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 185. Africa Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 186. Africa Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 187. Africa Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 188. North America Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2019-2024)
  • Table 189. North America Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 190. North America Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 191. North America Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 192. United States Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 193. United States Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 194. United States Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 195. Canada Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 196. Canada Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 197. Canada Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 198. Mexico Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2019-2024)
  • Table 199. Mexico Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2019-2024)
  • Table 200. Mexico Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2019-2024)
  • Table 201. Animal Antibiotics and Antimicrobials: by Type(USD/Units)
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Animal Antibiotics and Antimicrobials: by Type(USD Million)
  • Table 213. Animal Antibiotics and Antimicrobials Etracyclines , by Region USD Million (2027-2032)
  • Table 214. Animal Antibiotics and Antimicrobials Penicillins , by Region USD Million (2027-2032)
  • Table 215. Animal Antibiotics and Antimicrobials Macrolides , by Region USD Million (2027-2032)
  • Table 216. Animal Antibiotics and Antimicrobials Aminoglycosides , by Region USD Million (2027-2032)
  • Table 217. Animal Antibiotics and Antimicrobials Sulfonamides , by Region USD Million (2027-2032)
  • Table 218. Animal Antibiotics and Antimicrobials Fluoroquinolones , by Region USD Million (2027-2032)
  • Table 219. Animal Antibiotics and Antimicrobials Lincosamides , by Region USD Million (2027-2032)
  • Table 220. Animal Antibiotics and Antimicrobials Cephalosporins , by Region USD Million (2027-2032)
  • Table 221. Animal Antibiotics and Antimicrobials Other  , by Region USD Million (2027-2032)
  • Table 222. Animal Antibiotics and Antimicrobials: by Application(USD Million)
  • Table 223. Animal Antibiotics and Antimicrobials Food-producing Animals , by Region USD Million (2027-2032)
  • Table 224. Animal Antibiotics and Antimicrobials Companion Animals , by Region USD Million (2027-2032)
  • Table 225. Animal Antibiotics and Antimicrobials: by Mode of Delivery(USD Million)
  • Table 226. Animal Antibiotics and Antimicrobials Premixes , by Region USD Million (2027-2032)
  • Table 227. Animal Antibiotics and Antimicrobials Oral Powder , by Region USD Million (2027-2032)
  • Table 228. Animal Antibiotics and Antimicrobials Injection , by Region USD Million (2027-2032)
  • Table 229. South America Animal Antibiotics and Antimicrobials, by Country USD Million (2027-2032)
  • Table 230. South America Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 231. South America Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 232. South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 233. Brazil Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 234. Brazil Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 235. Brazil Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 236. Argentina Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 237. Argentina Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 238. Argentina Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 239. Rest of South America Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 240. Rest of South America Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 241. Rest of South America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 242. Asia Pacific Animal Antibiotics and Antimicrobials, by Country USD Million (2027-2032)
  • Table 243. Asia Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 244. Asia Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 245. Asia Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 246. China Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 247. China Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 248. China Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 249. Japan Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 250. Japan Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 251. Japan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 252. India Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 253. India Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 254. India Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 255. South Korea Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 256. South Korea Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 257. South Korea Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 258. Taiwan Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 259. Taiwan Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 260. Taiwan Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 261. Australia Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 262. Australia Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 263. Australia Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 264. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 265. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 266. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 267. Europe Animal Antibiotics and Antimicrobials, by Country USD Million (2027-2032)
  • Table 268. Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 269. Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 270. Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 271. Germany Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 272. Germany Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 273. Germany Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 274. France Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 275. France Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 276. France Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 277. Italy Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 278. Italy Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 279. Italy Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 280. United Kingdom Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 281. United Kingdom Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 282. United Kingdom Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 283. Netherlands Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 284. Netherlands Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 285. Netherlands Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 286. Rest of Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 287. Rest of Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 288. Rest of Europe Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 289. MEA Animal Antibiotics and Antimicrobials, by Country USD Million (2027-2032)
  • Table 290. MEA Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 291. MEA Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 292. MEA Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 293. Middle East Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 294. Middle East Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 295. Middle East Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 296. Africa Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 297. Africa Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 298. Africa Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 299. North America Animal Antibiotics and Antimicrobials, by Country USD Million (2027-2032)
  • Table 300. North America Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 301. North America Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 302. North America Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 303. United States Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 304. United States Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 305. United States Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 306. Canada Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 307. Canada Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 308. Canada Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 309. Mexico Animal Antibiotics and Antimicrobials, by Type USD Million (2027-2032)
  • Table 310. Mexico Animal Antibiotics and Antimicrobials, by Application USD Million (2027-2032)
  • Table 311. Mexico Animal Antibiotics and Antimicrobials, by Mode of Delivery USD Million (2027-2032)
  • Table 312. Animal Antibiotics and Antimicrobials Sales: by Type(K Tons)
  • Table 313. Animal Antibiotics and Antimicrobials Sales Etracyclines , by Region K Tons (2027-2032)
  • Table 314. Animal Antibiotics and Antimicrobials Sales Penicillins , by Region K Tons (2027-2032)
  • Table 315. Animal Antibiotics and Antimicrobials Sales Macrolides , by Region K Tons (2027-2032)
  • Table 316. Animal Antibiotics and Antimicrobials Sales Aminoglycosides , by Region K Tons (2027-2032)
  • Table 317. Animal Antibiotics and Antimicrobials Sales Sulfonamides , by Region K Tons (2027-2032)
  • Table 318. Animal Antibiotics and Antimicrobials Sales Fluoroquinolones , by Region K Tons (2027-2032)
  • Table 319. Animal Antibiotics and Antimicrobials Sales Lincosamides , by Region K Tons (2027-2032)
  • Table 320. Animal Antibiotics and Antimicrobials Sales Cephalosporins , by Region K Tons (2027-2032)
  • Table 321. Animal Antibiotics and Antimicrobials Sales Other  , by Region K Tons (2027-2032)
  • Table 322. Animal Antibiotics and Antimicrobials Sales: by Application(K Tons)
  • Table 323. Animal Antibiotics and Antimicrobials Sales Food-producing Animals , by Region K Tons (2027-2032)
  • Table 324. Animal Antibiotics and Antimicrobials Sales Companion Animals , by Region K Tons (2027-2032)
  • Table 325. Animal Antibiotics and Antimicrobials Sales: by Mode of Delivery(K Tons)
  • Table 326. Animal Antibiotics and Antimicrobials Sales Premixes , by Region K Tons (2027-2032)
  • Table 327. Animal Antibiotics and Antimicrobials Sales Oral Powder , by Region K Tons (2027-2032)
  • Table 328. Animal Antibiotics and Antimicrobials Sales Injection , by Region K Tons (2027-2032)
  • Table 329. South America Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2027-2032)
  • Table 330. South America Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 331. South America Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 332. South America Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 333. Brazil Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 334. Brazil Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 335. Brazil Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 336. Argentina Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 337. Argentina Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 338. Argentina Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 339. Rest of South America Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 340. Rest of South America Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 341. Rest of South America Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 342. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2027-2032)
  • Table 343. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 344. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 345. Asia Pacific Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 346. China Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 347. China Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 348. China Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 349. Japan Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 350. Japan Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 351. Japan Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 352. India Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 353. India Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 354. India Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 355. South Korea Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 356. South Korea Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 357. South Korea Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 358. Taiwan Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 359. Taiwan Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 360. Taiwan Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 361. Australia Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 362. Australia Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 363. Australia Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 364. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 365. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 366. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 367. Europe Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2027-2032)
  • Table 368. Europe Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 369. Europe Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 370. Europe Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 371. Germany Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 372. Germany Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 373. Germany Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 374. France Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 375. France Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 376. France Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 377. Italy Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 378. Italy Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 379. Italy Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 380. United Kingdom Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 381. United Kingdom Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 382. United Kingdom Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 383. Netherlands Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 384. Netherlands Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 385. Netherlands Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 386. Rest of Europe Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 387. Rest of Europe Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 388. Rest of Europe Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 389. MEA Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2027-2032)
  • Table 390. MEA Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 391. MEA Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 392. MEA Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 393. Middle East Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 394. Middle East Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 395. Middle East Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 396. Africa Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 397. Africa Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 398. Africa Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 399. North America Animal Antibiotics and Antimicrobials Sales, by Country K Tons (2027-2032)
  • Table 400. North America Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 401. North America Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 402. North America Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 403. United States Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 404. United States Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 405. United States Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 406. Canada Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 407. Canada Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 408. Canada Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 409. Mexico Animal Antibiotics and Antimicrobials Sales, by Type K Tons (2027-2032)
  • Table 410. Mexico Animal Antibiotics and Antimicrobials Sales, by Application K Tons (2027-2032)
  • Table 411. Mexico Animal Antibiotics and Antimicrobials Sales, by Mode of Delivery K Tons (2027-2032)
  • Table 412. Animal Antibiotics and Antimicrobials: by Type(USD/Units)
  • Table 413. Research Programs/Design for This Report
  • Table 414. Key Data Information from Secondary Sources
  • Table 415. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Antibiotics and Antimicrobials: by Type USD Million (2019-2024)
  • Figure 5. Global Animal Antibiotics and Antimicrobials: by Application USD Million (2019-2024)
  • Figure 6. Global Animal Antibiotics and Antimicrobials: by Mode of Delivery USD Million (2019-2024)
  • Figure 7. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 8. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 9. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 10. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 11. North America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 12. Global Animal Antibiotics and Antimicrobials: by Type K Tons (2019-2024)
  • Figure 13. Global Animal Antibiotics and Antimicrobials: by Application K Tons (2019-2024)
  • Figure 14. Global Animal Antibiotics and Antimicrobials: by Mode of Delivery K Tons (2019-2024)
  • Figure 15. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 16. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 17. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 18. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 19. North America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 20. Global Animal Antibiotics and Antimicrobials: by Type USD/Units (2019-2024)
  • Figure 21. Global Animal Antibiotics and Antimicrobials share by Players 2024 (%)
  • Figure 22. Global Animal Antibiotics and Antimicrobials share by Players (Top 3) 2024(%)
  • Figure 23. Global Animal Antibiotics and Antimicrobials share by Players (Top 5) 2024(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Zoetis, Inc. (United States) Revenue: by Geography 2024
  • Figure 27. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Merck & Co., Inc. (United States) Revenue: by Geography 2024
  • Figure 29. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Bayer AG (Germany) Revenue: by Geography 2024
  • Figure 31. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. Eli Lilly and Company (United States) Revenue: by Geography 2024
  • Figure 33. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 34. Virbac (France) Revenue: by Geography 2024
  • Figure 35. Boehringer Ingelheim GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Boehringer Ingelheim GmbH (Germany) Revenue: by Geography 2024
  • Figure 37. Ceva Sante Animale (France) Revenue, Net Income and Gross profit
  • Figure 38. Ceva Sante Animale (France) Revenue: by Geography 2024
  • Figure 39. Vetoquinol S.A. (France) Revenue, Net Income and Gross profit
  • Figure 40. Vetoquinol S.A. (France) Revenue: by Geography 2024
  • Figure 41. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 42. Sanofi (France) Revenue: by Geography 2024
  • Figure 43. Dechra Pharmaceuticals PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 44. Dechra Pharmaceuticals PLC (United Kingdom) Revenue: by Geography 2024
  • Figure 45. Global Animal Antibiotics and Antimicrobials: by Type USD Million (2027-2032)
  • Figure 46. Global Animal Antibiotics and Antimicrobials: by Application USD Million (2027-2032)
  • Figure 47. Global Animal Antibiotics and Antimicrobials: by Mode of Delivery USD Million (2027-2032)
  • Figure 48. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 49. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 50. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 51. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 52. North America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 53. Global Animal Antibiotics and Antimicrobials: by Type K Tons (2027-2032)
  • Figure 54. Global Animal Antibiotics and Antimicrobials: by Application K Tons (2027-2032)
  • Figure 55. Global Animal Antibiotics and Antimicrobials: by Mode of Delivery K Tons (2027-2032)
  • Figure 56. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 57. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 58. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 59. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 60. North America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 61. Global Animal Antibiotics and Antimicrobials: by Type USD/Units (2027-2032)
List of companies from research coverage that are profiled in the study
  • Zoetis, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Bayer AG (Germany)
  • Eli Lilly and Company (United States)
  • Virbac (France)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Sante Animale (France)
  • Vetoquinol S.A. (France)
  • Sanofi (France)
  • Dechra Pharmaceuticals PLC (United Kingdom)
Additional players considered in the study are as follows:
Elanco Animal Health (United States) , Novartis International AG (Germany)
Select User Access Type

Key Highlights of Report


Feb 2025 239 Pages 64 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Animal Antibiotics and Antimicrobials Market Quantitative research analysis
Global Animal Antibiotics and Antimicrobials Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Zoetis, Inc. (United States), Merck & Co., Inc. (United States), Bayer AG (Germany), Eli Lilly and Company (United States), Virbac (France), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), Sanofi (France) and Dechra Pharmaceuticals PLC (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Instances of Zoonotic Diseases will further Increase the Adoption " is seen as one of major influencing trends for Animal Antibiotics and Antimicrobials Market during projected period 2024-2032.
The Animal Antibiotics and Antimicrobials market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Animal Antibiotics and Antimicrobials Market Report?

Have a Query? Click Here

Other Related Reports

Medical Elastomers Comprehensive Study by Type (Thermoset Elastomers, Thermoplastic Elastomers), Application (Medical Tubes, Catheters, Gloves, Syringes, Medical Bags, Others), End-Users (Medical Dev...
$ 3350
Travelers Vaccines Comprehensive Study by Type (Mono Vaccines, Combination Vaccines), Application (Tourists, Students, Workers, Others), Disease (Meningococcal Vaccine, Japanese Encephalitis Vaccine,...
$ 3450
Healthcare Satellite Connectivity Comprehensive Study by Type (Medical Device, System & Software, Services), Application (EHealth, Telemedicine, Clinical Operations, Connected Imaging), System & Soft...
$ 3750
Baby Nasal Aspirators and Inhalers Comprehensive Study by Type (Electric Nasal Aspirators and Inhalers, Manual Nasal Aspirators and Inhalers), Application (Hospitals, Personnel, Others), Distribution...
$ 3650
Home Healthcare Comprehensive Study by Telehealth Solution (Home Telehealth Services, Home Telehealth Software, Home Telehealth Monitoring Devices), Services (Skilled Nursing Services, Rehabilitation...
$ 3750
Urinary Drainage Bags Comprehensive Study by Type (Legs Bags, Large Capacity Night Bags), End Users (Hospitals, Clinics, Ambulatory surgical centers, Home care), Capacity (500 ml, 1,000 ml, 2,000 ml,...
$ 3500